001028620 001__ 1028620
001028620 005__ 20250204113908.0
001028620 0247_ $$2doi$$a10.1093/sleep/zsae145
001028620 0247_ $$2ISSN$$a0161-8105
001028620 0247_ $$2ISSN$$a1550-9109
001028620 0247_ $$2datacite_doi$$a10.34734/FZJ-2024-04693
001028620 0247_ $$2pmid$$a38934787
001028620 0247_ $$2WOS$$aWOS:001285659400001
001028620 037__ $$aFZJ-2024-04693
001028620 082__ $$a610
001028620 1001_ $$0P:(DE-Juel1)190450$$aElberse, Jorik D$$b0$$ufzj
001028620 245__ $$aThe interplay between insomnia symptoms and Alzheimer’s Disease across three main brain networks
001028620 260__ $$aOxford$$bOxford Univ. Press$$c2024
001028620 3367_ $$2DRIVER$$aarticle
001028620 3367_ $$2DataCite$$aOutput Types/Journal article
001028620 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1729492234_18424
001028620 3367_ $$2BibTeX$$aARTICLE
001028620 3367_ $$2ORCID$$aJOURNAL_ARTICLE
001028620 3367_ $$00$$2EndNote$$aJournal Article
001028620 520__ $$aStudy ObjectivesInsomnia symptoms are prevalent along the trajectory of Alzheimer’s disease (AD), but the neurobiological underpinning of their interaction is poorly understood. Here, we assessed structural and functional brain measures within and between the default mode network (DMN), salience network (SN), and central executive network (CEN).MethodsWe selected 320 subjects from the ADNI database and divided by their diagnosis: cognitively normal (CN), Mild Cognitive Impairment (MCI), and AD, with and without self-reported insomnia symptoms. We measured the gray matter volume (GMV), structural covariance (SC), degrees centrality (DC), and functional connectivity (FC), testing the effect and interaction of insomnia symptoms and diagnosis on each index. Subsequently, we performed a within-group linear regression across each network and ROI. Finally, we correlated observed abnormalities with changes in cognitive and affective scores.ResultsInsomnia symptoms were associated with FC alterations across all groups. The AD group also demonstrated an interaction between insomnia and diagnosis. Within-group analyses revealed that in CN and MCI, insomnia symptoms were characterised by within-network hyperconnectivity, while in AD, within- and between-network hypoconnectivity was ubiquitous. SC and GMV alterations were non-significant in the presence of insomnia symptoms, and DC indices only showed network-level alterations in the CEN of AD individuals. Abnormal FC within and between DMN and CEN hubs was additionally associated with reduced cognitive function across all groups, and increased depressive symptoms in AD.ConclusionsWe conclude that patients with clinical AD present with a unique pattern of insomnia-related functional alterations, highlighting the profound interaction between both conditions.
001028620 536__ $$0G:(DE-HGF)POF4-5252$$a5252 - Brain Dysfunction and Plasticity (POF4-525)$$cPOF4-525$$fPOF IV$$x0
001028620 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
001028620 7001_ $$0P:(DE-Juel1)190448$$aSaberi, Amin$$b1
001028620 7001_ $$0P:(DE-Juel1)194451$$aAhmadi, Reihaneh$$b2$$ufzj
001028620 7001_ $$0P:(DE-HGF)0$$aChangizi, Monir$$b3
001028620 7001_ $$0P:(DE-Juel1)190453$$aBi, Hanwen$$b4$$ufzj
001028620 7001_ $$0P:(DE-Juel1)131684$$aHoffstaedter, Felix$$b5$$ufzj
001028620 7001_ $$0P:(DE-HGF)0$$aMander, Bryce A$$b6
001028620 7001_ $$0P:(DE-Juel1)131678$$aEickhoff, Simon B$$b7$$ufzj
001028620 7001_ $$0P:(DE-Juel1)188400$$aTahmasian, Masoud$$b8$$eCorresponding author
001028620 773__ $$0PERI:(DE-600)2056761-3$$a10.1093/sleep/zsae145$$gp. zsae145$$n10$$pzsae145$$tSleep$$v47$$x0161-8105$$y2024
001028620 8564_ $$uhttps://juser.fz-juelich.de/record/1028620/files/zsae145.pdf$$yOpenAccess
001028620 8564_ $$uhttps://juser.fz-juelich.de/record/1028620/files/zsae145.gif?subformat=icon$$xicon$$yOpenAccess
001028620 8564_ $$uhttps://juser.fz-juelich.de/record/1028620/files/zsae145.jpg?subformat=icon-1440$$xicon-1440$$yOpenAccess
001028620 8564_ $$uhttps://juser.fz-juelich.de/record/1028620/files/zsae145.jpg?subformat=icon-180$$xicon-180$$yOpenAccess
001028620 8564_ $$uhttps://juser.fz-juelich.de/record/1028620/files/zsae145.jpg?subformat=icon-640$$xicon-640$$yOpenAccess
001028620 909CO $$ooai:juser.fz-juelich.de:1028620$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
001028620 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)190450$$aForschungszentrum Jülich$$b0$$kFZJ
001028620 9101_ $$0I:(DE-HGF)0$$6P:(DE-Juel1)190450$$a HHU Düsseldorf$$b0
001028620 9101_ $$0I:(DE-HGF)0$$6P:(DE-Juel1)190450$$a MPI Leipzig$$b0
001028620 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)190448$$aForschungszentrum Jülich$$b1$$kFZJ
001028620 9101_ $$0I:(DE-HGF)0$$6P:(DE-Juel1)190448$$a Otto Hahn Group Cognitive Neurogenetics, Max Planck Institute for Human Cognitive and Brain Sciences , Leipzig$$b1
001028620 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)194451$$aForschungszentrum Jülich$$b2$$kFZJ
001028620 9101_ $$0I:(DE-HGF)0$$6P:(DE-Juel1)194451$$a Julius-Maximilians University of Würzburg$$b2
001028620 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)190453$$aForschungszentrum Jülich$$b4$$kFZJ
001028620 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131684$$aForschungszentrum Jülich$$b5$$kFZJ
001028620 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131678$$aForschungszentrum Jülich$$b7$$kFZJ
001028620 9101_ $$0I:(DE-HGF)0$$6P:(DE-Juel1)131678$$a HHU Düsseldorf$$b7
001028620 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)188400$$aForschungszentrum Jülich$$b8$$kFZJ
001028620 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5252$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
001028620 9141_ $$y2024
001028620 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-24
001028620 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-10-24
001028620 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
001028620 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-24
001028620 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
001028620 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2024-12-21$$wger
001028620 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-21
001028620 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-21
001028620 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-21
001028620 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-21
001028620 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2024-12-21
001028620 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-21
001028620 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-21
001028620 9201_ $$0I:(DE-Juel1)INM-7-20090406$$kINM-7$$lGehirn & Verhalten$$x0
001028620 980__ $$ajournal
001028620 980__ $$aVDB
001028620 980__ $$aUNRESTRICTED
001028620 980__ $$aI:(DE-Juel1)INM-7-20090406
001028620 9801_ $$aFullTexts